Back
Speaker illustration

Miss Eline Feyen

University of Antwerp, Antwerp (Belgium)

Member of:

Heart Failure Association of the ESC

An enthusiastic PhD student at the team of Physiopharmacology, University of Antwerp. During her research she obtained expertise in Immunocardiology, Oncology and Discovery Sciences by (high-throughput) screening and investigating a novel small-molecule treatment option related to fibrosis and heart failure.

Presentations Articles

Identification and characterization of small-molecule ERBB4 agonists as a treatment for heart failure

Event: Heart Failure 2022

Topic: Heart Failure

Session: New therapeutic approaches for heart failure

Access
Like
Thumbnail

Identification of small-molecule ERBB4 agonists for the treatment of heart failure

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Heart Failure

Session: Moderated poster 10 - Heart Failure

Access
Like
Thumbnail

ERBB4 and multiple microRNAs that target ERBB4 participate in pregnancy-related cardiomyopathy

Event: Heart Failure 2021

Topic: Pregnancy and Cardiovascular Disease

Session: Risk Factors and Prevention, Rehabilitation and Sports Cardiology, Cardiovascular Disease in Special Populations

Access
Like
Thumbnail

Heterozygous cardiomyocyte-specific deletion of ErbB4 sensitizes to development of pregnancy-related cardiomyopathy

Event: ESC Congress 2019

Topic: Heart Failure

Session: Other cardiovascular disease

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources